These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 20646063)

  • 21. Association of dopamine, serotonin, and nicotinic gene polymorphisms with methylphenidate response in ADHD.
    Tharoor H; Lobos EA; Todd RD; Reiersen AM
    Am J Med Genet B Neuropsychiatr Genet; 2008 Jun; 147B(4):527-30. PubMed ID: 17948872
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of acute and chronic administration of atomoxetine and methylphenidate on extracellular levels of noradrenaline, dopamine and serotonin in the prefrontal cortex and striatum of mice.
    Koda K; Ago Y; Cong Y; Kita Y; Takuma K; Matsuda T
    J Neurochem; 2010 Jul; 114(1):259-70. PubMed ID: 20403082
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Heteromerization between α
    Casadó-Anguera V; Moreno E; Sánchez-Soto M; Cai NS; Bonaventura J; Homar-Ruano P; Rubinstein M; Cortés A; Canela EI; Ferré S; Casadó V
    Pharmacol Res; 2021 Aug; 170():105745. PubMed ID: 34182128
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The dopamine D4 receptor is essential for hyperactivity and impaired behavioral inhibition in a mouse model of attention deficit/hyperactivity disorder.
    Avale ME; Falzone TL; Gelman DM; Low MJ; Grandy DK; Rubinstein M
    Mol Psychiatry; 2004 Jul; 9(7):718-26. PubMed ID: 14699433
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Attention-deficit hyperactivity disorder in adults: A systematic review and meta-analysis of genetic, pharmacogenetic and biochemical studies.
    Bonvicini C; Faraone SV; Scassellati C
    Mol Psychiatry; 2016 Jul; 21(7):872-84. PubMed ID: 27217152
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Polymorphisms of the dopamine D4 receptor, clinical outcome, and cortical structure in attention-deficit/hyperactivity disorder.
    Shaw P; Gornick M; Lerch J; Addington A; Seal J; Greenstein D; Sharp W; Evans A; Giedd JN; Castellanos FX; Rapoport JL
    Arch Gen Psychiatry; 2007 Aug; 64(8):921-31. PubMed ID: 17679637
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oral Administration of Methylphenidate (Ritalin) Affects Dopamine Release Differentially Between the Prefrontal Cortex and Striatum: A Microdialysis Study in the Monkey.
    Kodama T; Kojima T; Honda Y; Hosokawa T; Tsutsui KI; Watanabe M
    J Neurosci; 2017 Mar; 37(9):2387-2394. PubMed ID: 28154152
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Toward a new understanding of attention-deficit hyperactivity disorder pathophysiology: an important role for prefrontal cortex dysfunction.
    Arnsten AF
    CNS Drugs; 2009; 23 Suppl 1():33-41. PubMed ID: 19621976
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Methylphenidate modifies reward cue responses in adults with ADHD: An fMRI study.
    Furukawa E; da Costa RQM; Bado P; Hoefle S; Vigne P; Monteiro M; Wickens JR; Moll J; Tripp G; Mattos P
    Neuropharmacology; 2020 Jan; 162():107833. PubMed ID: 31689423
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effects of cocaine on regional brain glucose metabolism is attenuated in dopamine transporter knockout mice.
    Thanos PK; Michaelides M; Benveniste H; Wang GJ; Volkow ND
    Synapse; 2008 May; 62(5):319-24. PubMed ID: 18286542
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Depressed dopamine activity in caudate and preliminary evidence of limbic involvement in adults with attention-deficit/hyperactivity disorder.
    Volkow ND; Wang GJ; Newcorn J; Telang F; Solanto MV; Fowler JS; Logan J; Ma Y; Schulz K; Pradhan K; Wong C; Swanson JM
    Arch Gen Psychiatry; 2007 Aug; 64(8):932-40. PubMed ID: 17679638
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Profound decreases in dopamine release in striatum in detoxified alcoholics: possible orbitofrontal involvement.
    Volkow ND; Wang GJ; Telang F; Fowler JS; Logan J; Jayne M; Ma Y; Pradhan K; Wong C
    J Neurosci; 2007 Nov; 27(46):12700-6. PubMed ID: 18003850
    [TBL] [Abstract][Full Text] [Related]  

  • 33. DAT1 methylation is associated with methylphenidate response on oppositional and hyperactive-impulsive symptoms in children and adolescents with ADHD.
    Ding K; Yang J; Reynolds GP; Chen B; Shao J; Liu R; Qian Q; Liu H; Yang R; Wen J; Kang C
    World J Biol Psychiatry; 2017 Jun; 18(4):291-299. PubMed ID: 27676100
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Changes in Endogenous Dopamine Induced by Methylphenidate Predict Functional Connectivity in Nonhuman Primates.
    Birn RM; Converse AK; Rajala AZ; Alexander AL; Block WF; McMillan AB; Christian BT; Filla CN; Murali D; Hurley SA; Jenison RL; Populin LC
    J Neurosci; 2019 Feb; 39(8):1436-1444. PubMed ID: 30530859
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of methylphenidate on functional magnetic resonance relaxometry of the cerebellar vermis in boys with ADHD.
    Anderson CM; Polcari A; Lowen SB; Renshaw PF; Teicher MH
    Am J Psychiatry; 2002 Aug; 159(8):1322-8. PubMed ID: 12153824
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High sibling correlation on methylphenidate response but no association with DAT1-10R homozygosity in Dutch sibpairs with ADHD.
    van der Meulen EM; Bakker SC; Pauls DL; Oteman N; Kruitwagen CL; Pearson PL; Sinke RJ; Buitelaar JK
    J Child Psychol Psychiatry; 2005 Oct; 46(10):1074-80. PubMed ID: 16178931
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dopamine vs noradrenaline: inverted-U effects and ADHD theories.
    Levy F
    Aust N Z J Psychiatry; 2009 Feb; 43(2):101-8. PubMed ID: 19153917
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dopamine D4 receptor, but not the ADHD-associated D4.7 variant, forms functional heteromers with the dopamine D2S receptor in the brain.
    González S; Rangel-Barajas C; Peper M; Lorenzo R; Moreno E; Ciruela F; Borycz J; Ortiz J; Lluís C; Franco R; McCormick PJ; Volkow ND; Rubinstein M; Floran B; Ferré S
    Mol Psychiatry; 2012 Jun; 17(6):650-62. PubMed ID: 21844870
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacogenetics predictors of methylphenidate efficacy in childhood ADHD.
    Myer NM; Boland JR; Faraone SV
    Mol Psychiatry; 2018 Sep; 23(9):1929-1936. PubMed ID: 29230023
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    Naumova D; Grizenko N; Sengupta SM; Joober R
    World J Biol Psychiatry; 2019 Jul; 20(6):486-495. PubMed ID: 29182037
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.